The expression of DOK5 was also correlated with the patients' survival in the lung cancer (OS: HR = 0.85, 95% CI = 0.75 to 0.96, P = 0.0126; PFS: HR = 1.02, 95% CI = 0.84 to 1.24, P = 0.83; PPS: HR = 0.86, 95% CI = 0.67 to 1.11, P = 0.25; Figures 3(k)–3(m)). Here, DOK5 is linked to lung carcinoma.